BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27082897)

  • 1. GPR119 Agonist AS1269574 Activates TRPA1 Cation Channels to Stimulate GLP-1 Secretion.
    Chepurny OG; Holz GG; Roe MW; Leech CA
    Mol Endocrinol; 2016 Jun; 30(6):614-29. PubMed ID: 27082897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.
    Chepurny OG; Bertinetti D; Diskar M; Leech CA; Afshari P; Tsalkova T; Cheng X; Schwede F; Genieser HG; Herberg FW; Holz GG
    Mol Endocrinol; 2013 Aug; 27(8):1267-82. PubMed ID: 23798572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.
    Arifin SA; Paternoster S; Carlessi R; Casari I; Ekberg JH; Maffucci T; Newsholme P; Rosenkilde MM; Falasca M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1132-1141. PubMed ID: 29883799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
    Lauffer LM; Iakoubov R; Brubaker PL
    Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cytotoxicity and intracellular calcium-signalling following activation of the calcium-permeable ion channels TRPV1 and TRPA1.
    Stueber T; Eberhardt MJ; Caspi Y; Lev S; Binshtok A; Leffler A
    Cell Calcium; 2017 Dec; 68():34-44. PubMed ID: 29129206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
    Islam D; Zhang N; Wang P; Li H; Brubaker PL; Gaisano HY; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E174-81. PubMed ID: 18854429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca(2+) influx.
    Eiki J; Saeki K; Nagano N; Iino T; Yonemoto M; Takayenoki-Iino Y; Ito S; Nishimura T; Sato Y; Bamba M; Watanabe H; Sasaki K; Ohyama S; Kanatani A; Nagase T; Yada T
    J Endocrinol; 2009 Jun; 201(3):361-7. PubMed ID: 19332449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.
    Hansen KB; Rosenkilde MM; Knop FK; Wellner N; Diep TA; Rehfeld JF; Andersen UB; Holst JJ; Hansen HS
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1409-17. PubMed ID: 21778222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
    Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
    Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.
    Hodge D; Glass LL; Diakogiannaki E; Pais R; Lenaghan C; Smith DM; Wedin M; Bohlooly-Y M; Gribble FM; Reimann F
    Peptides; 2016 Mar; 77():16-20. PubMed ID: 26144594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
    Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
    Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxynivalenol (Vomitoxin)-Induced Cholecystokinin and Glucagon-Like Peptide-1 Release in the STC-1 Enteroendocrine Cell Model Is Mediated by Calcium-Sensing Receptor and Transient Receptor Potential Ankyrin-1 Channel.
    Zhou HR; Pestka JJ
    Toxicol Sci; 2015 Jun; 145(2):407-17. PubMed ID: 25787141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
    Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
    Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells.
    Cao DS; Zhong L; Hsieh TH; Abooj M; Bishnoi M; Hughes L; Premkumar LS
    PLoS One; 2012; 7(5):e38005. PubMed ID: 22701540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Cell Inactivation of
    Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.